This is the authors' abstract. We don't add key points for this paper.
Technological developments have led to the worldwide introduction of universal neonatal screens for hearing impairment. Although automated behavioural tests were the first to be employed, it has been the development of simple, sensitive, objective oto-acoustic emission testing and automated auditory brainstem response recording that has made such screens possible. Investigation has demonstrated that the emission test and the auditory brainstem (ABR) employing a 30 dB stimulus are equally valid. The specificity critically depends upon the age of maternity testing, but a false positive rate of 8% at discharge is typical when an initial oto-acoustic emission test is undertaken in the maternity unit. This is reduced to 1% or less by implementing a second out-patient test, or by undertaking an automated ABR before hospital discharge. Combination protocols using both techniques have therefore been recommended. A reduction in the numbers referred for diagnostic audiological assessment has been confirmed. Irrespective of test method, screens have identified around 1.2/1000 with a permanent childhood hearing impairment, and this yield is doubled if mild and unilateral losses are included. The median age at which habilitation has been introduced for all degrees of deafness has been reduced to the second half of infancy, with programmes reducing the median age of hearing aid fitting for severe or profound deafness to under 4 months. The provision of appropriate habilitation at this age presents new challenges. However, qualitative review of the many screens now being undertaken throughout the world confirms both their practicability and their effectiveness.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Peter Watkin (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: